New microwave probe aims to zap lung tumors without cutting
NCT ID NCT07291973
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new device called the FlexAblate Microwave Ablation System that uses heat from microwaves to destroy small lung cancer nodules. It is for people who cannot have surgery or choose not to. The trial will check if the device safely and completely treats the tumor, with follow-up scans and tests over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Microwave ablation device (FlexAblate Microwave Transbronchial Ablation System)
What this could lead to
If successful, this could offer a less invasive treatment option for people with small lung cancer nodules who cannot have surgery.
What could go wrong
This is an early-stage study with only 43 participants, so results may not apply to everyone. The procedure carries risks like bleeding or infection, and it may not fully destroy the tumor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMC Ambroise Paré - Hartmann
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Bartholomew's Hospital
RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University College London Hospitals NHS Foundation Trust
RECRUITINGLondon, United Kingdom
Contact Email: •••••@•••••